BBLGWBone Biologics Corporation
17.93USD+9.06%Mkt Cap: P/E: Last update: 2026-05-29

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…

Indicators:|

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit
Net Income (TTM)-3.11M USD
Revenue/Share
Last Price17.93 USD
Fiscal Year End
MR Quarter
Employees2
CountryUS
SectorBasic Materials
IndustryChemicals
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B5.99
EPS (TTM)-0.14
EPS (Forward)
52W Range
8.30035% of range35.95
52W High35.95 USD
52W Low8.300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.81%
ROA-53.64%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-2.69M USD
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt-5.33M USD
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio13.85
Quick Ratio12.77
Book Value/Sh2.995 USD
Cash/Share2.971 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float1.79M
Insiders
Institutions
Technical
SMA 5019.09 (-6.1%)
SMA 20017.37 (+3.2%)
Beta0.53
S&P 52W Chg27.94%
Avg Vol (30d)113
Avg Vol (10d)70
Technical Indicators
RSI (14)39.0
MACD-1.0202
MACD Signal-0.7707
MACD Hist.-0.2494
BB Upper22.55 USD
BB Middle18.38 USD
BB Lower14.22 USD
BB Width45.32%
ATR (14)0.7901 USD
Vol Ratio (20d)0.00x